Comparison of 5-hydroxytryptophan signaling pathway characteristics in diarrhea-predominant irritable bowel syndrome and ulcerative colitis

World Journal of Gastroenterology

Volumn 22, Issue 12, 2016, Pages 3451-3459

  Yu, Feng Yan ^a   Huang, Shao Gang ^b   Zhang, Hai Yan ^b   Ye, Hua ^a   Chi, Hong Gang ^a   Zou, Ying ^a   Lv, Ru Xi ^a   Zheng, Xue Bao ^a  

^a GUANGDONG MEDICAL UNIVERSITY   (China)

^b GUANGDONG PROVINCIAL HOSPITAL OF CHINESE MEDICINE   (China)

Author keywords

5 Hydroxytryptophan; Diarrhea predominant irritable bowel syndrome; Stomach type diarrhea; Ulcerative colitis in remission

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; 5 HYDROXYTRYPTOPHAN; MESSENGER RNA; SEROTONIN 3 RECEPTOR; SEROTONIN 4 RECEPTOR; SEROTONIN 7 RECEPTOR; SEROTONIN RECEPTOR; SEROTONIN TRANSPORTER; SLC6A4 PROTEIN, HUMAN; TPH1 PROTEIN, HUMAN; TRYPTOPHAN HYDROXYLASE;

ABDOMINAL DISCOMFORT; ABDOMINAL PAIN; ADULT; ARTICLE; COLON BIOPSY; COMPARATIVE STUDY; CONTROLLED STUDY; DIARRHEA; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; HUMAN TISSUE; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; PAIN THRESHOLD; PATHOGENESIS; PROSPECTIVE STUDY; PROTEIN EXPRESSION; REMISSION; SIGNAL TRANSDUCTION; ULCERATIVE COLITIS; BLOOD; COLITIS, ULCERATIVE; COLON; COMPLICATION; DEFECATION; GENETICS; INNERVATION; INTESTINE MUCOSA; IRRITABLE BOWEL SYNDROME; METABOLISM; MIDDLE AGED; NOCICEPTION; PATHOPHYSIOLOGY; YOUNG ADULT;

5-HYDROXYTRYPTOPHAN; ABDOMINAL PAIN; ADULT; COLITIS, ULCERATIVE; COLON; DEFECATION; DIARRHEA; FEMALE; HUMANS; HYDROXYINDOLEACETIC ACID; INTESTINAL MUCOSA; IRRITABLE BOWEL SYNDROME; MALE; MIDDLE AGED; PAIN PERCEPTION; PAIN THRESHOLD; PROSPECTIVE STUDIES; RECEPTORS, SEROTONIN; REMISSION INDUCTION; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SIGNAL TRANSDUCTION; TRYPTOPHAN HYDROXYLASE; YOUNG ADULT;

EID: 84996555479     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v22.i12.3451     Document Type: Article

References (16)

1. Basilisco G. [Pathogenesis of irritable bowel syndrome: current understanding]. Recenti Prog Med 2007; 98: 543-547 [PMID: 18044402]
2. Dinan TG, O'Keane V, O'Boyle C, Chua A, Keeling PW. A comparison of the mental status, personality profiles and life events of patients with irritable bowel syndrome and peptic ulcer disease. Acta Psychiatr Scand 1991; 84: 26-28 [PMID: 1927562]
3. Barbara G, Cremon C, De Giorgio R, Dothel G, Zecchi L, Bellacosa L, Carini G, Stanghellini V, Corinaldesi R. Mechanisms underlying visceral hypersensitivity in irritable bowel syndrome. Curr Gastroenterol Rep 2011; 13: 308-315 [PMID: 21537962 DOI: 10.1007/s11894-011-0195-7]
4. Keszthelyi D, Troost FJ, Masclee AA. Irritable bowel syndrome: methods, mechanisms, and pathophysiology. Methods to assess visceral hypersensitivity in irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol 2012; 303: G141-G154 [PMID: 22595988 DOI: 10.1152/ajpgi.00060.2012]
5. La JH, Kim TW, Sung TS, Kang JW, Kim HJ, Yang IS. Visceral hypersensitivity and altered colonic motility after subsidence of inflammation in a rat model of colitis. World J Gastroenterol 2003; 9: 2791-2795 [PMID: 14669335 DOI: 10.3748/wjg.v9.i12.2791]
6. Lucas A, Cobelens PM, Kavelaars A, Heijnen CJ, Holtmann G, Haag S, Gerken G, Langhorst J, Dobos GJ, Schedlowski M, Elsenbruch S. Disturbed in vitro adrenergic modulation of cytokine production in inflammatory bowel diseases in remission. J Neuroimmunol 2007; 182: 195-203 [PMID: 17112600]
7. Ohman L, Simrén M. New insights into the pathogenesis and pathophysiology of irritable bowel syndrome. Dig Liver Dis 2007; 39: 201-215 [PMID: 17267314]
8. Greenwood-Van Meerveld B, Venkova K, Hicks G, Dennis E, Crowell MD. Activation of peripheral 5-HT receptors attenuates colonic sensitivity to intraluminal distension. Neurogastroenterol Motil 2006; 18: 76-86 [PMID: 16371086]
9. Narboux-Nême N, Pavone LM, Avallone L, Zhuang X, Gaspar P. Serotonin transporter transgenic (SERTcre) mouse line reveals developmental targets of serotonin specific reuptake inhibitors (SSRIs). Neuropharmacology 2008; 55: 994-1005 [PMID: 18789954 DOI: 10.1016/j.neuropharm.2008.08.020]
10. Chen YL, Huang XQ, Xu SJ, Liao JB, Wang RJ, Lu XF, Xie YL, Zhou FS, Su ZR, Lai XP. Relieving visceral hyperalgesia effect of Kangtai capsule and its potential mechanisms via modulating the 5-HT and NO level in vivo. Phytomedicine 2013; 20: 249-257 [PMID: 23141427 DOI: 10.1016/j.phymed.2012.09.027]
11. Morteau O, Hachet T, Caussette M, Bueno L. Experimental colitis alters visceromotor response to colorectal distension in awake rats. Dig Dis Sci 1994; 39: 1239-1248 [PMID: 8200256]
12. O'Hara JR, Lomax AE, Mawe GM, Sharkey KA. Ileitis alters neuronal and enteroendocrine signalling in guinea pig distal colon. Gut 2007; 56: 186-194 [PMID: 16931576]
13. Mawe GM, Coates MD, Moses PL. Review article: intestinal serotonin signalling in irritable bowel syndrome. Aliment Pharmacol Ther 2006; 23: 1067-1076 [PMID: 16611266]
14. El-Salhy M, Gilja OH, Gundersen D, Hatlebakk JG, Hausken T. Endocrine cells in the ileum of patients with irritable bowel syndrome. World J Gastroenterol 2014; 20: 2383-2391 [PMID: 24605036 DOI: 10.3748/wjg.v20.i9.2383]
15. Barbara G. Revival of 5-HT3 antagonism as treatment of IBS-D? Gut 2014; 63: 1530-1532 [PMID: 24465028 DOI: 10.1136/gutjnl-2013-306457]
16. El-Salhy M, Gundersen D, Hatlebakk JG, Gilja OH, Hausken T. Abnormal rectal endocrine cells in patients with irritable bowel syndrome. Regul Pept 2014; 188: 60-65 [PMID: 24316398 DOI: 10.1016/j.regpep.2013.11.005]